-
Mashup Score: 11A living WHO guideline on drugs for covid-19 - 2 year(s) ago
Updates This is the eleventh version (tenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. Clinical question What is the role of drugs in the treatment of patients with covid-19? Context The evidence base for therapeutics for covid-19 is evolving with numerous randomised controlled…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3A living WHO guideline on drugs for covid-19 - 2 year(s) ago
Updates This is the eleventh version (tenth update) of the living guideline, replacing earlier versions (available as data supplements). New recommendations will be published as updates to this guideline. Clinical question What is the role of drugs in the treatment of patients with covid-19? Context The evidence base for therapeutics for covid-19 is evolving with numerous randomised controlled…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Current evidence does not justify using colchicine to treat non-severe illness from covid-19, and fluvoxamine shouldn’t be used outside of clinical trials, say a @WHO Guideline Development Group (GDG) panel of international experts: https://t.co/NK5zhZJcps #RapidRecs @theMAGICapp https://t.co/8K3M2iv866
-
-
Mashup Score: 13A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drugs in the treatment of patients with covid-19? New recommendation Pre-prints of four randomised trials (from a larger adaptive randomised master protocol) among patients with non-severe illness, and the RECOVERY trial among severe and critically ill patients, triggered this guideline update. This resulted in a conditional recommendation to use a…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Updated @WHO #LivingGuidance on #COVID19 provides a recommendation for casirivimab and imdevimab for two specific groups of patients with #COVID19 #RapidRecs #BMJInfographic https://t.co/FAyGbsLm25 https://t.co/8bzK6wu3zq
-
-
Mashup Score: 17A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drugs in the treatment of patients with covid-19? New recommendation Pre-prints of four randomised trials (from a larger adaptive randomised master protocol) among patients with non-severe illness, and the RECOVERY trial among severe and critically ill patients, triggered this guideline update. This resulted in a conditional recommendation to use a…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Updated @WHO #LivingGuidance on #COVID19 provides a recommendation for casirivimab and imdevimab for two specific groups of patients with #COVID19 #RapidRecs #BMJInfographic https://t.co/8p5DUL5xHQ https://t.co/9DfSEkq1Mp
-
-
Mashup Score: 5
-
This guideline makes a weak recommendation to offer a trial of non-inhaled medical cannabis or cannabinoids, in addition to standard care (if not sufficient), for people with chronic pain. Includes an interactive visual summary #BMJInfographic @will_s_t https://t.co/GqYxshmAOB https://t.co/eP6ecRz2t0
Read the original tweet here
Source: TwitterCategories: Latest Headlines, PayerTweet-
New evidence-based recommendation from BMJ #RapidRecs 📰Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline ▶️https://t.co/xAjHD8snrd
-
-
Mashup Score: 34A living WHO guideline on drugs to prevent covid-19 - 3 year(s) ago
Clinical question What is the role of drugs in preventing covid-19? Why does this matter? There is widespread interest in whether drug interventions can be used for the prevention of covid-19, but there is uncertainty about which drugs, if any, are effective. The first version of this living guideline focuses on the evidence for hydroxychloroquine. Subsequent updates will cover other drugs being…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have #COVID19 say a @WHO Guideline Development Group (GDG) panel of international experts #RapidRecs https://t.co/UQbY797OA5
-
-
Mashup Score: 18A living WHO guideline on drugs to prevent covid-19 - 3 year(s) ago
Clinical question What is the role of drugs in preventing covid-19? Why does this matter? There is widespread interest in whether drug interventions can be used for the prevention of covid-19, but there is uncertainty about which drugs, if any, are effective. The first version of this living guideline focuses on the evidence for hydroxychloroquine. Subsequent updates will cover other drugs being…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have #COVID19 say a @WHO Guideline Development Group (GDG) panel of international experts #RapidRecs https://t.co/bjzN0F7tQZ
-
-
Mashup Score: 1A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with covid-19 regardless of disease severity. These recommendations follow the publication of results from the WHO SOLIDARITY…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
#BMJInfographic provides an interactive summary of @WHO living guidance which makes strong recommendations against the use of hydroxychloroquine & lopinavir-ritonavir in patients with #COVID19 regardless of disease severity: https://t.co/WqcdNGLMw9 #RapidRecs
-
-
Mashup Score: 4A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with covid-19 regardless of disease severity. These recommendations follow the publication of results from the WHO SOLIDARITY…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The latest version of this @WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with #COVID19 regardless of disease severity: https://t.co/6e07qp2dPj #RapidRecs
-
-
Mashup Score: 2A living WHO guideline on drugs for covid-19 - 3 year(s) ago
Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with covid-19 regardless of disease severity. These recommendations follow the publication of results from the WHO SOLIDARITY…
Source: The BMJCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The latest version of this @WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with #COVID19 regardless of disease severity: https://t.co/IChMPWotgy #RapidRecs
-
Current evidence does not justify using colchicine to treat non-severe illness from covid-19, and fluvoxamine shouldn’t be used outside of clinical trials, say a @WHO panel of international experts: https://t.co/7wfv4pJ4eW #RapidRecs @theMAGICapp https://t.co/U62incJmVi